Post trials’ data, need to revise treatment regimen for Covid-19: Experts
Results of the global `Solidarity Trial’ which declared the widely-prescribed anti-viral drug, Remdesivir ineffective for saving lives or shortening duration of hospital stay, will lead to curbing its indiscriminate use for Covid-19 patients in India.